Skip to content

Exposure in vivo: procedural fidelity and effectiveness in adults with chronic musculoskeletal pain (CMSP) directly following implementation in a rehabilitation center

Exposure in vivo: procedural fidelity and effectiveness in adults with chronic musculoskeletal pain (CMSP) directly following implementation in a rehabilitation center - Exposure in vivo in chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50836
Enrollment
12
Registered
2021-04-29
Start date
2021-03-01
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronische pijn Musculoskeletal pain

Interventions

Exposure in vivo treatment: a 12-week module including 16 treatment sessions of one hour each.

Sponsors

Centrum Integrale Revalidatie (CIR revalidatie)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - chronic musculoskeletal pain consisting at least three months and diagnosed by a general practitioner or medical specialist; - aged >= 18 years; and - an indication for the exposure in vivo treatment given by an interdisciplinary team including a physiatrist, physical therapist, and psychologist.

Exclusion criteria

Exclusion criteria: Any of the contra-indications described by Verbunt et al., for instance, an unstable medical, emotional-personal and/or social situation.

Design outcomes

Secondary

MeasureTime frame
Pain and fatigue, illness perception and coping, patients rating of improvement and satisfaction, retention, physical functioning, emotional functioning, symptoms and adverse events, and medical consumption. Procedural fidelity is also a secondary outcome.

Primary

MeasureTime frame
Accomplishment of patient*specific goals and pain-related disability (activities and participation).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)